Technological advances have always played a major role in the field of Rhinology and Skull Base Surgery. As minimally invasive approaches to the sinuses, orbit, and skull base were developed, pioneering surgeons relied heavily on specialized tools to access and target different anatomic reaches of the head. Since then, technology has continued to evolve in pace with our techniques and areas of focus, with a major emphasis being on multifunctional design and ergonomics. There has been a refinement in foundational tools such as microdebriders that now permit more effective drilling and are cautery enabled; enhancement in our surgical navigation systems that are providing “multimodal” information; and an explosion of bioabsorbable packing materials, including the first ever drug-eluting stent for use in the sinuses.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2rbtH3T
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction che...
-
Abstract Purpose Overcoming the flaws of current data management conditions in head and neck oncology could enable integrated informatio...
-
Differential Evolution Optimization of the SAR Distribution for Head and Neck Hyperthermia. IEEE Trans Biomed Eng. 2016 Nov 14;: Auth...
-
This paper investigates the control and synchronization of a class of chaotic systems with switched output which is assumed to be switched b...
-
RT @ecancer_espanol : Abiraterone for metastatic, hormone sensitive, prostate cancer https://t.co/xa9jVlFrCg https://t.co/dj5XAacWCF fro...
-
Melanocyte development is orchestrated by a complex interconnecting regulatory network of genes and synergistic interactions. Piebaldism and...
-
Abstract Hepatocarcinogenesis is a multi-step process characterized by progressive cellular and molecular dedifferentiation of hepatocytes ...
-
Purpose: 18 F-fluoroestradiol (FES) PET scans measure regional estrogen binding, and 18 F-fluorodeoxyglucose (FDG) PET measures tumor glycol...
-
Publication date: 1 August 2017 Source: Cancer Letters, Volume 400 Author(s): Amr S. Abu Lila, Naoto Moriyoshi, Masakazu Fukushima, Cheng-...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου